Company Profile
Updated: 05-JUN-09Compugen Ltd.
International public company
72 Pinchas Rosen St., Tel Aviv, 69512, Israel
()972 03 765 85 85, 972 03 765 85 55 fax, http://www.cgen.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: The company, a genomics-based drug and diagnostic discovery business, increases the probability of successful development of novel drug and diagnostic products by incorporating ideas and methods from mathematics, computer science and physics into the disciplines of biology, organic chemistry and medicine. This unique capability results in powerful predictive models and discovery engines, which are both advancing the understanding of important biological phenomena and enabling the discovery of numerous potential therapeutic products and diagnostic markers. The company has an early-stage in-house pipeline consisting of selected therapeutic protein candidates discovered by the company; additional discoveries have been out-licensed for development
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Compugen Announces Preeclampsia Biomarker Collaboration.
Angiogenesis Weekly; 11/20/2009; 1525 words; Compugen Ltd. (NASDAQ:CGEN) announced that it has signed a research and license...diagnostic company requested that their identity not be disclosed (see also Compugen Ltd.). At present, attempts at early diagnosis of preeclampsia rely largely...
Two million diabetic Israelis possible in 20 years time. Number of diagnosed cases here has increased by 10 percent in just the last two years
Jerusalem Post; 11/12/2009; 689 words; ...obese and inactive. Meanwhile, Compugen Ltd. has announced the discovery and...biomarker was discovered using Compugen's GeneVa platform, which consists...to the two studies performed by Compugen, approximately 15% of the Caucasian...
Compugen Presents DAC Blockers Platform and Initial Product Candidates at Fifth Peptide Engineering Meeting in Barcelona, Spain.
Engineering Business Journal; 11/11/2009; 1248 words; ...Peptide Engineering Meeting, Compugen Ltd. (NASDAQ:CGEN) project...Pharmaceutical Industries. In 2002, Compugen established an affiliate, Evogene Ltd. www.evogene.com (TASE...Environment, Software, Compugen Ltd. This article was prepared...
Compugen Reports Third Quarter 2009 Financial Results.(Financial report)
Biotech Week; 11/11/2009; 1402 words; Compugen Ltd. (NASDAQ:CGEN) reported financial results for the third quarter ended September 30, 2009 (see also Compugen Ltd.). Martin Gerstel, Compugen's co-CEO stated, "The industry interest and collaboration...
Tuesday's Pick!! GSAE - Green Star Alternative Energy, Inc. "Green Star Erects Wind Sensor at Ram".
M2 Presswire; 11/10/2009; 4040 words; ...Restaurants, Inc.) (NASDAQ : BRKR - Bruker Corp.) (NASDAQ: CBST - Cubist Pharmaceuticals, Inc.) (NASDAQ: CGEN - Compugen Ltd.) www.StockMarketingInc.com To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc...
Recent News Articles
- Compugen Ltd. to Review Third Quarter 2009 Results on Tuesday, October 27, 2009.(Financial report)
Business Wire - October 20, 2009 - Compugen Ltd. to Review Second Quarter 2009 Financial Results on Tuesday, July 28, 2009.(Financial report)
Business Wire - July 20, 2009 - Compugen Ltd - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Compugen Ltd. to Review First Quarter 2009 Financial Results on Tuesday, May 12, 2009.(Financial report)
Business Wire - May 05, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning